[go: up one dir, main page]

AU8003800A - Methods and compositions for treating neurobehavioral disorders - Google Patents

Methods and compositions for treating neurobehavioral disorders

Info

Publication number
AU8003800A
AU8003800A AU80038/00A AU8003800A AU8003800A AU 8003800 A AU8003800 A AU 8003800A AU 80038/00 A AU80038/00 A AU 80038/00A AU 8003800 A AU8003800 A AU 8003800A AU 8003800 A AU8003800 A AU 8003800A
Authority
AU
Australia
Prior art keywords
compositions
treating
methods
neurobehavioral disorders
neurobehavioral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80038/00A
Inventor
Joyce Corinne Bechthold
Thomas Duff Lilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU8003800A publication Critical patent/AU8003800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU80038/00A 1999-10-08 2000-10-06 Methods and compositions for treating neurobehavioral disorders Abandoned AU8003800A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US15860499P 1999-10-08 1999-10-08
US60158604 1999-10-08
US16404999P 1999-11-08 1999-11-08
US60164049 1999-11-08
US16606899P 1999-11-17 1999-11-17
US60166068 1999-11-17
US20104300P 2000-05-01 2000-05-01
US60201043 2000-05-01
PCT/US2000/027894 WO2001026642A2 (en) 1999-10-08 2000-10-06 Methods and compositions for treating neurobehavioral disorders

Publications (1)

Publication Number Publication Date
AU8003800A true AU8003800A (en) 2001-04-23

Family

ID=27496343

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80038/00A Abandoned AU8003800A (en) 1999-10-08 2000-10-06 Methods and compositions for treating neurobehavioral disorders

Country Status (2)

Country Link
AU (1) AU8003800A (en)
WO (1) WO2001026642A2 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759437B2 (en) 1999-10-04 2004-07-06 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity including cysteine
US6403657B1 (en) 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
US6423349B1 (en) * 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
AU2002236527A1 (en) * 2000-11-30 2002-06-11 The Health Research Institute Nutrient supplements and methods for treating autism and for preventing the onset of autism
CA2445512C (en) * 2001-04-25 2010-10-12 Cobalz Limited A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
DE10149108A1 (en) * 2001-10-05 2003-04-30 Degussa Bioactives Deutschland Use of phosphatidylserine to treat Attention Deficit Disorder (ADHD)
EP1302196A1 (en) * 2001-10-16 2003-04-16 Habinger, René, Ing. Mag. Toothpaste for promotion of intelligence
NL1019368C2 (en) * 2001-11-14 2003-05-20 Nutricia Nv Preparation for improving receptor performance.
US8142799B2 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco High potency clinical anti-craving treatment and method of use
US8142800B1 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco Oral high potency clinical anti-craving treatment and method of use
EP1490073A4 (en) * 2002-03-21 2006-02-01 Martin C Hinz Serotonin and catecholamine system segment optimization techonology
AU2003299311A1 (en) * 2002-12-18 2004-07-09 University Of Zurich Treatment of neuro-psychiatric disorders
WO2004082609A2 (en) * 2003-03-14 2004-09-30 Pro-Health, Inc. Composition and method for appetite and carving suppression and mood enhancement
CA2593563A1 (en) * 2005-01-05 2006-07-13 Magd Ahmed Kotb Abdalla Taurine synthesis, production and utility as a medicine
IL188681A0 (en) * 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
JP2011528321A (en) * 2008-06-21 2011-11-17 ケンバー，エルエルシー Nutrigenomics method and composition
JP2013506678A (en) * 2009-09-30 2013-02-28 クレイトン ビーリー，ハーラン Smoking cessation and nutritional supplements that maintain weight
US20120244213A1 (en) * 2009-12-17 2012-09-27 Liora Emanuel Methods for the treatment of speech impediments
ES2375391B1 (en) * 2010-08-17 2013-07-31 Vitae Natural Nutrition, S.L. COMPOSITION OF NUTRITIONAL COMPLEMENT.
CN102526103B (en) * 2010-12-07 2013-11-13 西藏海思科药业集团股份有限公司 Multi-trace element injection and preparation method thereof
US20130090356A1 (en) * 2011-06-24 2013-04-11 Jon D. Kaiser Compositions and methods for treatment of neuropsychological deficits
US9040082B2 (en) * 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US10894062B2 (en) * 2012-08-10 2021-01-19 Aquavit Pharmaceuticals, Inc. Vitamin supplement compositions for injection
US10980865B2 (en) 2012-08-10 2021-04-20 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
EP2737809A1 (en) * 2012-12-03 2014-06-04 MüMed Beverage containing amino acids, suitable for use in the prevention and treatment of mental disorders
CN104055759B (en) * 2014-06-16 2016-08-31 重庆工商大学 A kind of pharmaceutical composition and application thereof
AU2016205225A1 (en) * 2015-01-07 2017-08-17 Trigemina, Inc. Magnesium-containing oxytocin formulations and methods of use
US20160331709A1 (en) * 2015-05-13 2016-11-17 Wow Llc??? Balancing an Unbalanced Sympathetic Nervous System
PL3442560T4 (en) 2016-04-12 2025-04-28 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
KR101840003B1 (en) 2017-02-07 2018-03-19 한국과학기술연구원 composition or kit for diagnosing behavioral addiction and method of detecting cholecystokinin for diagnosis of behavioral addiction using the same
US11464756B1 (en) 2017-05-19 2022-10-11 Jerry Darm Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US12433904B2 (en) 2019-04-17 2025-10-07 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
RU2709501C1 (en) * 2019-10-15 2019-12-18 Виктор Александрович Сисев Pharmaceutical composition for parenteral drip introduction
WO2021125934A1 (en) * 2019-12-18 2021-06-24 Unibiolabs Internacional S.A De C.V Formulations for use in the treatment of different types of addictions and dependence on addictive substances
BR112022017433A2 (en) * 2020-03-11 2022-10-18 Purdue Pharma Lp COMPOSITIONS AND METHODS FOR NALOXONE DISTRIBUTION
DE102020008090A1 (en) 2020-11-17 2022-05-19 Vivant Biotechnology Gmbh Active ingredient composition
DE102020130273A1 (en) 2020-11-17 2022-05-19 Vivant Biotechnology Gmbh Active ingredient composition
EP4491023A4 (en) * 2022-03-09 2025-06-18 Kaneka Corporation COMPOSITION FOR COVERING PLANT SEEDS
AU2023288088A1 (en) * 2022-06-24 2025-01-30 Hikma Pharmaceuticals Usa Inc. Oxytocin formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2640230B2 (en) * 1987-07-31 1997-08-13 雪印乳業株式会社 Liquid sterile enteral nutrition in kit form composed of multiple liquids
DE69323731T2 (en) * 1992-11-10 1999-07-22 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo FOOD COMPOSITION

Also Published As

Publication number Publication date
WO2001026642A3 (en) 2002-05-10
WO2001026642A2 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AU2001285159A1 (en) Methods for treating endocrine disorders
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
AU2003238561A1 (en) Compositions and methods for treating gynaecological disorders
AU3877900A (en) Compositions and methods for preventing and treating sexual dysfunctions
AU7360000A (en) Methods and compositions for preventing and treating prostate disorders
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU4033900A (en) Compositions and methods for treating cell proliferation disorders
AU5042000A (en) Methods of treating proliferative disorders
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AUPQ872800A0 (en) Compositions and methods for treating cardiovascular disorders
AU6798000A (en) Compounds, compositions and methods for treating influenza
AU5169200A (en) Methods and compositions for treating breakthrough pain
AU5097099A (en) Methods and compositions for cancer treatment
AU2003297259A1 (en) Methods and compositions for treating neurological disorders
AU5330599A (en) Methods and compositions for treating and preventing certain psychiatric and medical disorders using moclobemide
AU1472101A (en) Methods and compositions for diagnosing and treating chromosome 18q related disorders
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AUPQ925400A0 (en) Methods and compositions for treating gastro-intesinal disorders
AUPQ206999A0 (en) Methods and compositions for treating gastro-intestinal disorders
AU4486500A (en) Therapeutic compositions and methods for treating tumors
AU2002361711A1 (en) METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
AU3886397A (en) Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase